Skip to main content

FDA Expedited Programs

Meaning

FDA Expedited Programs are formal regulatory mechanisms established by the U.S. Food and Drug Administration (FDA) specifically to accelerate the development and subsequent review of new therapeutic drugs intended to treat serious medical conditions and address a demonstrable unmet medical need. These critical programs, which include designations like Fast Track, Breakthrough Therapy, Accelerated Approval, and Priority Review, are intentionally designed to bring potentially life-saving or significantly life-improving therapies to patients much sooner. They fundamentally reflect the agency’s commitment to balancing the urgent need for timely patient access with the rigorous scientific standards of safety and efficacy.